Johnson & Johnson will anchor a new startup incubator at the NJ Innovation Hub in New Brunswick, aiming to grow healthcare ...
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
Monday's verdict comes after the same plaintiffs' firm, Dean Omar, won a $65.5 million talc award on Friday in Minnesota. Johnson & Johnson said it would appeal what it called the 'egregious and ...
While 2025 has been a strong year for Johnson & Johnson on the stock market, it has struggled over the past few years. The drugmaker had to contend with government drug price negotiations that ...
Johnson & Johnson's nipocalimab has won approval in China, the U.S. drugmaker said on its WeChat social media ...
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website on Friday, CBS News exclusively learned. The pharmaceutical ...
Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales resilience. Their deal with the Trump Administration eliminates tariffs in exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results